One in Five Experience Rebound COVID After Antiviral Drug, New Study Shows

  At a glance: New study shows that viral rebound with Paxlovid is more common than previously believed. Clinicians should counsel patients about the possible risk of transmitting virus during rebound. A new study by Harvard Medical School researchers at Massachusetts General Hospital and Brigham and Women’s Hospital has found that one in five individuals […]

Related Keywords

Massachusetts ,United States ,Harvard University ,Yumeko Kawano ,Manishc Choudhary ,Rebeccaf Gilbert ,Shruti Sagar ,Jonathan Li ,Amyk Barczak ,Gregorye Edelstein ,Caitlin Marino ,Sarahp Hammond ,Zahra Reynolds ,Julie Boucau ,Dessie Tien ,Mamadou Barry ,Jacobe Lemieux ,Mark Siedner ,Yijia Li ,Zachary Wallace ,Rockib Uddin ,Pfizer ,Harvard Medical School ,Massachusetts Consortium For Pathogen Readiness ,Llura Gund Award For Rheumatoid Arthritis Research ,Ragon Institute ,Public Health Solutions ,Department Of Medicine ,Harvard University Center ,National Institutes Of Health ,National Institute Of Arthritis ,Massachusetts Consortium On Pathogen Readiness ,Glaxosmithkline ,Variants Program ,Massachusetts General Hospital ,Massachusetts Consortium ,Pathogen Readiness ,Post Vaccination Viral Characteristics Study ,National Institutes ,National Institute ,Skin Diseases ,Llura Gund Award ,Rheumatoid Arthritis Research ,Public Health ,